| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |